Contineum Therapeutics, Inc. (CIK: 0001855175) EDGAR, Information, Filings... CompaniesBIO.Com

Contineum Therapeutics, Inc.

Mailing address
10578 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, Delaware, 92121
Phone
(858) 333-5280
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

Contineum Therapeutics, Inc. (CIK: 0001855175) is an American company incorporated in the state of California. Head office is located at 10578 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, California, 92121. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Contineum Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Contineum Therapeutics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
8-K	Document	Current report filing Acc-no: 0001437749-25-029349 (34 Act) Size: KB	Sep-18-2025	001-42001 251321818
SCHEDULE 13G/A	Document	Acc-no: 0000950170-25-108947 (34 Act) Size: KB	Aug-14-2025	005-94496 251219776
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001437749-25-024852 (34 Act) Size: KB	Aug-05-2025	001-42001 251185129
8-K	Document	Current report filing Acc-no: 0001437749-25-024849 (34 Act) Size: KB	Aug-05-2025	001-42001 251185018
SCHEDULE 13G/A	Document	Acc-no: 0000038777-25-000140 (34 Act) Size: KB	Aug-05-2025	005-94496 251183491
SCHEDULE 13G	Document	Acc-no: 0001415889-25-020291 (34 Act) Size: KB	Jul-25-2025	005-94496 251152285
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-25-021373 ( Act) Size: 0 KB	Jun-26-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-25-021372 ( Act) Size: 0 KB	Jun-26-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-25-021371 ( Act) Size: 0 KB	Jun-26-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-25-021369 ( Act) Size: 0 KB	Jun-26-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-25-021367 ( Act) Size: 0 KB	Jun-26-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-25-021366 ( Act) Size: 0 KB	Jun-26-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-25-021365 ( Act) Size: 0 KB	Jun-26-2025
8-K	Document	Current report filing Acc-no: 0001437749-25-021343 (34 Act) Size: KB	Jun-26-2025	001-42001 251080420
EFFECT	Document	Acc-no: 9999999995-25-001732 (33 Act) Size: KB	May-23-2025	333-287275 25984037
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001437749-25-018028 ( Act) Size: KB	May-21-2025
UPLOAD	Document	Acc-no: 0000000000-25-005357 ( Act) Size: KB	May-20-2025	333-287275
SCHEDULE 13G/A	Document	Acc-no: 0000950170-25-072735 (34 Act) Size: KB	May-15-2025	005-94496 25954081
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001437749-25-016878 (33 Act) Size: KB	May-14-2025	333-287276 25946644
8-K	Document	Current report filing Acc-no: 0001437749-25-016877 (34 Act) Size: KB	May-14-2025	001-42001 25946591

Recent 20 filings. View all Contineum Therapeutics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Contineum Therapeutics, Inc. overview
Contineum Therapeutics, Inc. job
Contineum Therapeutics, Inc. stock
Contineum Therapeutics, Inc. ownership
Contineum Therapeutics, Inc. CEO
Contineum Therapeutics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.